Literature DB >> 16988834

Choroidal neovascularisation after surgical removal of submacular lipid plaques in diabetic maculopathy.

Daniela Suesskind1, Faik Gelisken, Karl U Bartz-Schmidt.   

Abstract

BACKGROUND: We report a case of choroidal neovascularisation (CNV) that developed after surgical removal of submacular lipid plaques secondary to diabetic maculopathy.
METHODS: A 73-year-old man with diabetic maculopathy underwent standard pars plana vitrectomy and surgical removal of the submacular lipid plaques.
RESULTS: Preoperative visual acuity was 20/200. Funduscopy revealed a macular oedema and subretinal lipid plaques at the macula. Nine months after surgery visual acuity had dropped to 20/320 and subfoveal CNV was diagnosed by fluorescein angiography. Observational management was chosen. At the last examination, 27 months after surgery, visual acuity had worsened to 20/500 and a CNV scar was seen at the macula.
CONCLUSIONS: CNV development should be kept in mind as a possible complication of surgical removal of submacular lipid plaques in patients with diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988834     DOI: 10.1007/s00417-006-0435-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.

Authors:  A P Ciardella; J Klancnik; W Schiff; G Barile; K Langton; S Chang
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

2.  Long-term results of vitrectomy for removal of submacular hard exudates in patients with diabetic maculopathy.

Authors:  Kaori Takaya; Yukihiko Suzuki; Hideyuki Mizutani; Tomoki Sakuraba; Mitsuru Nakazawa
Journal:  Retina       Date:  2004-02       Impact factor: 4.256

3.  Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates.

Authors:  Moncef Khairallah; Hatem Zeghidi; Ahmed Ladjimi; Salim Ben Yahia; Sonia Attia; Sonia Zaouali; Riadh Messaoud
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

4.  Iatrogenic choroidal neovascularization occurring in patients undergoing macular surgery.

Authors:  Eugene W M Ng; Neil M Bressler; David S Boyer; Eugene de Juan
Journal:  Retina       Date:  2002-12       Impact factor: 4.256

5.  Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group.

Authors:  D S Fong; P P Segal; F Myers; F L Ferris; L D Hubbard; M D Davis
Journal:  Arch Ophthalmol       Date:  1997-07

6.  New surgical approach for removing massive foveal hard exudates in diabetic macular edema.

Authors:  H Takagi; A Otani; J Kiryu; Y Ogura
Journal:  Ophthalmology       Date:  1999-02       Impact factor: 12.079

7.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

8.  Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

Authors:  E Y Chew; M L Klein; F L Ferris; N A Remaley; R P Murphy; K Chantry; B J Hoogwerf; D Miller
Journal:  Arch Ophthalmol       Date:  1996-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.